MarketPulse

Long COVID

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Tiziana Life Sciences

Tiziana's Long COVID Treatment Shows Promise in Peer-Reviewed Study

Tiziana Life Sciences reports positive preclinical data for intranasal foralumab in treating Long COVID neuroinflammation and cognitive dysfunction.
TLSAALSAlzheimer's disease
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Tevogen Bio Advances Long COVID Therapy With Expanded HLA Coverage and Digital Care Platform

Tevogen Bio ($TVGN) expands T-cell therapy coverage to 65% of U.S. population and pursues digital care platform acquisition to advance Long COVID treatment.
TVGNTVGNWclinical trialprecision medicine